Navigation Links
Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial
Date:8/24/2009

NATICK, Mass., Aug. 24 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing final results from the landmark MADIT-CRT trial on Tuesday, September 1, at 8:00 a.m. ET / 2:00 p.m. Barcelona time.

The call will be hosted by Ray Elliott, President and Chief Executive Officer; Fred Colen, Executive Vice President and Group President, Cardiac Rhythm Management; and Arthur Moss, M.D., Professor of Medicine at the University of Rochester Medical Center and Principal Investigator of the trial.

The final results from the MADIT-CRT trial will be presented during a Hot Line session at the European Society of Cardiology (ESC) Congress in Barcelona and published in a major peer-reviewed journal. The Company plans to issue a press release simultaneous with an ESC Hot Line press conference to be held in Barcelona on September 1.

The live webcast and archived replay of this call will be available at www.bostonscientific.com in the Investor Relations section. The webcast is also being distributed over Thomson Financial's Investor Distribution Network via two locations: www.earnings.com, which is accessible to the public, and www.streetevents.com, a password-protected event management site.

To ensure a timely connection to the live webcast it is recommended that users register at least 15 minutes before the webcast begins. A replay of the webcast will begin at approximately 11:00 a.m. ET on September 1 and will be available for one year.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

    CONTACT:  Paul Donovan
              508-650-8541
              Media Relations
              Boston Scientific Corporation

              Larry Neumann
              508-650-8696
              Investor Relations
              Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
2. Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
3. Boston Scientific to Participate in Wachovia Conference
4. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
5. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
6. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
7. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
8. Boston Scientific Welcomes Launch of Syntax Score Website
9. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
10. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
11. Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... 2016 , ... Net-Translators, an industry-leading provider of translation, ... and improved website. In an on-going effort to further educate customers and emphasize ... how the company designs and delivers thorough, high-quality results for its growing customer ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... over the years and Open Access publishing is one of the popular publication ... 700+ open access journals and 3000+ International Conferences across ...
(Date:2/9/2016)... , February 9, 2016 ... replace paper and protect IP   E-WorkBook 10 ... be rolled out in Germany early ... protect valuable IP. Users will be able to search for ... experiment as part of the application, to boost collaboration and ...
(Date:2/8/2016)... 8, 2016 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... finalists for clean technology companies in the TSX Venture 50 ... companies listed on the TSX Venture Exchange, in each of ... clean technology & life sciences, diversified industries and technology ... to return on investment, market cap growth, trading volume and ...
Breaking Biology Technology:
(Date:2/3/2016)... --> --> Fourth quarter ... up 1,187% compared with fourth quarter of 2014. Gross margin ... (loss: 30.0). Earnings per share increased to SEK 6.39 (loss: ... (neg: 74.7). , --> --> ... 2,900.5 M (233.6), up 1,142% compared with 2014. Gross margin ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS devices ... primarily focused on medical screening and diagnostic ... parameters. Wearable devices that facilitate and assure ... of movement are being bolstered through new ... biomedical signal acquisition coupled with wireless connectivity ...
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
Breaking Biology News(10 mins):